Drugmakers build on early 2023 gains
March 10, 2023 | 15:00
While making profits in 2022 from market recovery, Vietnamese drug giants are restructuring to strengthen sales and new products to gain market share, both at home and abroad.
Drugmakers yearning for MA clarity
June 01, 2022 | 09:00
Despite the government’s strong request for facilitation of marketing authorisation renewal, foreign drugmakers are still waiting for the renewal of expired authorisations, triggering concerns over a possible future shortfall of drugs.
Drugmakers prepare to offer home vaccines to the world
September 02, 2021 | 17:00
As Vietnam is stepping up its homegrown vaccine development, there is a high chance for Vietnamese vaccine producers to expand their presence in the global pharmaceuticals market.
Drugmakers fight to attain approval
July 01, 2020 | 10:00
Switzerland’s drug maker Novartis Pharma Services AG has announced a GMP qualification for Lek Pharmaceuticals d.d. within the scope of certification for medicines in Vietnam, but doubts have been raised about recognition in regards to the valuable and much-sought-after PIC/S-GMP and EU-GMP standards.
Drugmakers tackling disrupted supply chain
April 24, 2020 | 11:00
While gaining advantage in the first quarter of 2020 amid the coronavirus outbreak, Vietnamese drug giants are predicted to face challenges in the upcoming months due to faults in the global ingredient supply chain.
Local drugmakers ride on to ethical medicine
October 27, 2019 | 09:00
Although strong solutions exist, the biggest Vietnamese drugmakers reported poor performance in the first three quarters of 2019, putting their future targets at risk.
Mobile Version